{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:33:00Z","timestamp":1787650380674,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>It is important to differentiate between radiation injury (RI) and tumor recurrence (TR) in patients with glioma after surgery and radiotherapy. Our objective was to evaluate the use of dynamic susceptibility contrast-enhanced perfusion-weighted imaging to distinguish between TR and RI in patients with glioma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Relevant studies published until October 2021 were identified in the PubMed, Embase, and Cochrane Library databases. Stata v12.0 and RevMan 5.3 were used for meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, the meta-analysis incorporated 13 retrospective studies that included 513 patients with 522 lesions. Among the 522 lesions, 329 lesions were TRs and 193 lesions were RIs. The pooled relative cerebral blood volume value was significantly greater in the TR group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.00001) with significant heterogeneity (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 88%). The pooled sensitivity, specificity, positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were 83% (95 confidence interval [CI], 77%\u201388%), 85% (95 CI, 77%\u201391%), 5.60 (95 CI, 3.61\u20138.70), and 0.20 (95% CI, 0.14\u20130.27), respectively. The heterogeneity of sensitivity (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 33.18%), specificity (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 24.01%), PLR (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 0.00%), and NLR (<jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 6.68%) is not significant. The area under the receiver operating characteristic curve was 0.91 (95% CI, 0.88\u20130.93). The 3.0 T magnetic resonance imaging, high-grade glioma, and Europe\/America patient subgroups showed PLR greater than 5 and NLR less than 0.2. There was no significant indication of publication bias in the analysis (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.496).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>It is concluded that dynamic susceptibility contrast-enhanced perfusion-weighted imaging is effective for the diagnostic differentiation between TR and RI in patients with glioma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000001356","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T18:00:05Z","timestamp":1660586405000},"page":"938-944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic Performance of Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in Differentiating Recurrence From Radiation Injury in Postoperative Glioma: A Meta-analysis"],"prefix":"10.1097","volume":"46","author":[{"given":"Hui-Mei","family":"Zhang","sequence":"first","affiliation":[{"name":"Radiology Department, Binzhou People's Hospital, Binzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Huo","sequence":"additional","affiliation":[{"name":"Radiology Department, Binzhou People's Hospital, Binzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Long","family":"Wang","sequence":"additional","affiliation":[{"name":"Radiology Department, Binzhou People's Hospital, Binzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Radiology Department, Xuzhou Central Hospital, Xuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"bib1-20250802","first-page":"1550","article-title":"Diagnostic performance of PET and perfusion-weighted imaging in differentiating tumor recurrence or progression from radiation necrosis in posttreatment gliomas: a review of literature","volume":"41","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.18632\/oncotarget.14922","article-title":"Mean cerebral blood volume is an effective diagnostic index of recurrent and radiation injury in glioma patients: a meta-analysis of diagnostic test","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"suppl 4","key":"bib3-20250802","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16 suppl 4","year":"2014","journal-title":"Neuro Oncol"},{"key":"bib4-20250802","first-page":"18","article-title":"New therapeutic approaches for malignant glioma: in search of the Rosetta stone","volume":"4","year":"2012","journal-title":"F1000 Med Rep"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s00330-019-06548-3","article-title":"Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma","volume":"30","year":"2020","journal-title":"Eur Radiol"},{"key":"bib6-20250802","first-page":"5813951","article-title":"MRI in glioma immunotherapy: evidence, pitfalls, and perspectives","volume":"2017","year":"2017","journal-title":"J Immunol Res"},{"key":"bib7-20250802","first-page":"206","article-title":"Principles and current trends in the correlative evaluation of glioma with advanced MRI techniques and PET","volume":"22","year":"2019","journal-title":"Hell J Nucl Med"},{"key":"bib8-20250802","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.3390\/ijms150711832","article-title":"The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence","volume":"15","year":"2014","journal-title":"Int J Mol Sci"},{"key":"bib9-20250802","first-page":"81","article-title":"Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy","volume":"48","year":"2010","journal-title":"Folia Neuropathol"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/neuonc\/nos307","article-title":"Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies","volume":"15","year":"2013","journal-title":"Neuro Oncol"},{"key":"bib11-20250802","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2532090007","article-title":"Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"253","year":"2009","journal-title":"Radiology"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3174\/ajnr.A3876","article-title":"Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis","volume":"35","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11547-013-0371-y","article-title":"Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach","volume":"119","year":"2014","journal-title":"Radiol Med"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jmri.22801","article-title":"Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects","volume":"35","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jon.12460","article-title":"Role of FDG-PET\/MRI, FDG-PET\/CT, and dynamic susceptibility contrast perfusion MRI in differentiating radiation necrosis from tumor recurrence in glioblastomas","volume":"28","year":"2018","journal-title":"J Neuroimaging"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3174\/ajnr.A1377","article-title":"Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements","volume":"30","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib17-20250802","first-page":"282","article-title":"Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging","volume":"17","year":"2010","journal-title":"Acad Radiol"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3174\/ajnr.A5952","article-title":"Utility of dynamic susceptibility contrast perfusion-weighted mr imaging and 11C-methionine PET\/CT for differentiation of tumor recurrence from radiation injury in patients with high-grade gliomas","volume":"40","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.acra.2013.09.003","article-title":"Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease","volume":"20","year":"2013","journal-title":"Acad Radiol"},{"key":"bib20-20250802","first-page":"551","article-title":"Value of MR perfusion weighted imaging in diagnosis of glioma recurrence and cerebral radiation injuries","volume":"35","year":"2013","journal-title":"J Dalian Med Univ"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.01.009","article-title":"Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging","volume":"129","year":"2018","journal-title":"Radiother Oncol"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1754-9485.2011.02315.x","article-title":"Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging","volume":"55","year":"2011","journal-title":"J Med Imaging Radiat Oncol"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinimag.2012.02.016","article-title":"MRI perfusion in determining pseudoprogression in patients with glioblastoma","volume":"37","year":"2013","journal-title":"Clin Imaging"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","year":"2011","journal-title":"Ann Intern Med"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.2472070898","article-title":"Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"247","year":"2008","journal-title":"Radiology"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3174\/ajnr.A0899","article-title":"Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade","volume":"29","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3174\/ajnr.A0688","article-title":"Role of perfusion CT in glioma grading and comparison with conventional MR imaging features","volume":"28","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib28-20250802","first-page":"20170426","article-title":"Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis","volume":"91","year":"2018","journal-title":"Br J Radiol"},{"key":"bib29-20250802","first-page":"159","article-title":"Application analysis of functional magnetic resonance imaging in postoperative recurrence and radiation injury of gliomas","volume":"3","year":"2019","journal-title":"Ying Xiang Yan Jiu Yu Yi Xue Ying Yong"},{"key":"bib30-20250802","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.acra.2011.05.006","article-title":"MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury","volume":"18","year":"2011","journal-title":"Acad Radiol"},{"key":"bib31-20250802","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ejrad.2014.09.018","article-title":"Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis","volume":"83","year":"2014","journal-title":"Eur J Radiol"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3174\/ajnr.A4398","article-title":"Comparison of the diagnostic accuracy of DSC- and dynamic contrast-enhanced MRI in the preoperative grading of astrocytomas","volume":"36","year":"2015","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T23:14:07Z","timestamp":1754176447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001356","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}